FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096875294> ?p ?o ?g. }

• W2096875294 endingPage "927" @default.
• W2096875294 startingPage "921" @default.
• W2096875294 abstract "Albuminuria is an established risk marker for both cardiovascular and renal outcomes. Albuminuria can be reduced with drugs that block the renin-angiotensin system (RAS). We questioned whether the short-term drug-induced change in albuminuria would predict the long-term cardioprotective efficacy of RAS intervention.We analyzed data from Reduction in Endpoints in Non-insulin dependent diabetes mellitus with the Angiotensin II Antagonist Losartan (RENAAL), a double-blind, randomized trial in 1513 type 2 diabetic patients with nephropathy, focusing on the relationship between the prespecified cardiovascular end point (composite) or hospitalization for heart failure and baseline or reduction in albuminuria. Patients with high baseline albuminuria (> or =3 g/g creatinine) had a 1.92-fold (95% CI, 1.54 to 2.38) higher risk for the cardiovascular end point and a 2.70-fold (95% CI, 1.94 to 3.75) higher risk for heart failure compared with patients with low albuminuria (<1.5 g/g). Among all available baseline risk markers, albuminuria was the strongest predictor of cardiovascular outcome. The association between albuminuria and cardiovascular outcome was driven by those patients who also had a renal event. Modeling of the initial 6-month change in risk parameters showed that albuminuria reduction was the only predictor for cardiovascular outcome: 18% reduction in cardiovascular risk for every 50% reduction in albuminuria and a 27% reduction in heart failure risk for every 50% reduction in albuminuria.Albuminuria is an important factor predicting cardiovascular risk in patients with type 2 diabetic nephropathy. Reducing albuminuria in the first 6 months appears to afford cardiovascular protection in these patients." @default.
• W2096875294 created "2016-06-24" @default.
• W2096875294 creator A5003493851 @default.
• W2096875294 creator A5004435991 @default.
• W2096875294 creator A5016263167 @default.
• W2096875294 creator A5023556434 @default.
• W2096875294 creator A5041006587 @default.
• W2096875294 creator A5045497276 @default.
• W2096875294 creator A5046420696 @default.
• W2096875294 creator A5048460362 @default.
• W2096875294 creator A5049961217 @default.
• W2096875294 creator A5078490088 @default.
• W2096875294 date "2004-08-24" @default.
• W2096875294 modified "2023-10-14" @default.
• W2096875294 title "Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy" @default.
• W2096875294 cites W180946569 @default.
• W2096875294 cites W1963542379 @default.
• W2096875294 cites W1967754661 @default.
• W2096875294 cites W1968446955 @default.
• W2096875294 cites W1983269730 @default.
• W2096875294 cites W2007190763 @default.
• W2096875294 cites W2008426639 @default.
• W2096875294 cites W2013093313 @default.
• W2096875294 cites W2014759828 @default.
• W2096875294 cites W2017268330 @default.
• W2096875294 cites W2031484324 @default.
• W2096875294 cites W2042069668 @default.
• W2096875294 cites W2056976690 @default.
• W2096875294 cites W2059346848 @default.
• W2096875294 cites W2084004196 @default.
• W2096875294 cites W2128122485 @default.
• W2096875294 cites W2135285685 @default.
• W2096875294 cites W2137408480 @default.
• W2096875294 cites W2170707143 @default.
• W2096875294 cites W2335631045 @default.
• W2096875294 cites W2562329777 @default.
• W2096875294 cites W3156148333 @default.
• W2096875294 cites W3198570063 @default.
• W2096875294 cites W4238183455 @default.
• W2096875294 doi "https://doi.org/10.1161/01.cir.0000139860.33974.28" @default.
• W2096875294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15302780" @default.
• W2096875294 hasPublicationYear "2004" @default.
• W2096875294 type Work @default.
• W2096875294 sameAs 2096875294 @default.
• W2096875294 citedByCount "685" @default.
• W2096875294 countsByYear W20968752942012 @default.
• W2096875294 countsByYear W20968752942013 @default.
• W2096875294 countsByYear W20968752942014 @default.
• W2096875294 countsByYear W20968752942015 @default.
• W2096875294 countsByYear W20968752942016 @default.
• W2096875294 countsByYear W20968752942017 @default.
• W2096875294 countsByYear W20968752942018 @default.
• W2096875294 countsByYear W20968752942019 @default.
• W2096875294 countsByYear W20968752942020 @default.
• W2096875294 countsByYear W20968752942021 @default.
• W2096875294 countsByYear W20968752942022 @default.
• W2096875294 countsByYear W20968752942023 @default.
• W2096875294 crossrefType "journal-article" @default.
• W2096875294 hasAuthorship W2096875294A5003493851 @default.
• W2096875294 hasAuthorship W2096875294A5004435991 @default.
• W2096875294 hasAuthorship W2096875294A5016263167 @default.
• W2096875294 hasAuthorship W2096875294A5023556434 @default.
• W2096875294 hasAuthorship W2096875294A5041006587 @default.
• W2096875294 hasAuthorship W2096875294A5045497276 @default.
• W2096875294 hasAuthorship W2096875294A5046420696 @default.
• W2096875294 hasAuthorship W2096875294A5048460362 @default.
• W2096875294 hasAuthorship W2096875294A5049961217 @default.
• W2096875294 hasAuthorship W2096875294A5078490088 @default.
• W2096875294 hasBestOaLocation W20968752942 @default.
• W2096875294 hasConcept C126322002 @default.
• W2096875294 hasConcept C134018914 @default.
• W2096875294 hasConcept C141341695 @default.
• W2096875294 hasConcept C159641895 @default.
• W2096875294 hasConcept C164705383 @default.
• W2096875294 hasConcept C2776174234 @default.
• W2096875294 hasConcept C2777180221 @default.
• W2096875294 hasConcept C2779922275 @default.
• W2096875294 hasConcept C2780091579 @default.
• W2096875294 hasConcept C2781184683 @default.
• W2096875294 hasConcept C555293320 @default.
• W2096875294 hasConcept C71924100 @default.
• W2096875294 hasConceptScore W2096875294C126322002 @default.
• W2096875294 hasConceptScore W2096875294C134018914 @default.
• W2096875294 hasConceptScore W2096875294C141341695 @default.
• W2096875294 hasConceptScore W2096875294C159641895 @default.
• W2096875294 hasConceptScore W2096875294C164705383 @default.
• W2096875294 hasConceptScore W2096875294C2776174234 @default.
• W2096875294 hasConceptScore W2096875294C2777180221 @default.
• W2096875294 hasConceptScore W2096875294C2779922275 @default.
• W2096875294 hasConceptScore W2096875294C2780091579 @default.
• W2096875294 hasConceptScore W2096875294C2781184683 @default.
• W2096875294 hasConceptScore W2096875294C555293320 @default.
• W2096875294 hasConceptScore W2096875294C71924100 @default.
• W2096875294 hasIssue "8" @default.
• W2096875294 hasLocation W20968752941 @default.
• W2096875294 hasLocation W20968752942 @default.
• W2096875294 hasLocation W20968752943 @default.
• W2096875294 hasOpenAccess W2096875294 @default.

• next